A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013. - Wong SF; Unger JM; Wade JL 3rd; Wagner LI; Lacouture ME; Humphries KC; Moseley A; Arnold K; Velasco MR Jr; Floyd JD; Esparaz BT; Barzi A; et al. (Journal of patient-reported outcomes, 2020)